Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High-Content and Phenotypic Screening Europe 2018

High-Content and Phenotypic Screening Europe 2018



Keynote Speakers


Matthew Daniels
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford


Stefan Dubel
Full Professor and Director, Technische Universit├Ąt Braunschweig


Paul French
Professor, Department of Physics and Photonics Group, Imperial College London


Gary Gintant
Senior Research Fellow, Abbvie


David Hay
Chair of Tissue Engineering, MRC Centre for Regenerative Medicine, University of Edinburgh


Stephen Helliwell
Senior Investigator, Novartis Institutes for BioMedical Research


Robert Williams
Chief Drug Development Scientist, Cancer Research UK

Overview

High-Content & Phenotypic Screening 2018 is part of Select Biosciences Innovations in Drug Discovery 2018 Conference to be held in Cambridge, UK.
which together with Stem Cells in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 explores the emerging trends and technologies impacting Drug Discovery, circa 2018.

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High-Content technologies and Phenotypic Screening applications.

Topics to be covered include 3D-cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and technology/tools vendors, helping you to find solutions and build collaborations.

Information and Local Registration Facilities for this Conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Agenda Topics

  • High-Content Analysis and Phenotypic Screening for New Targets
  • Image Analysis and Data Management Tools
  • Phenotypic and High Content Screening of 3D-Model Systems
  • Phenotypic Drug Discovery

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Distinguished Faculty

Nicholas Hannan, Assistant Professor, University of Nottingham
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
Alice P├ębay, Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia
Sanjay Sinha, BHF Senior Research Fellow, University of Cambridge
Davide Danovi, Director, Cell Phenotyping Platform, Kings College London
Peter O'Brien, Head of Clinical Pathology, University College Dublin
Jacqueline Chuah, Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star
E. Sally Ward, Professor, Texas A&M University Health Science Center
Hugh Byrne, Professor, Dublin Institute of Technology
Wing Chang, R&D Director, STEMCELL Technologies
Win-Yan Chan, Research Scientist, UCB
Simon Hufton, Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)
Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV
Tristan Vaughan, Vice President, R&D, Antibody Discovery and Protein Engineering, MedImmune Ltd


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks